Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mechanical forces influence the growth and metabolism of a variety of cells, including cultured neonatal rat ventricular myocytes. To determine whether mechanical activity affected the synthesis and turnover of
myosin heavy chain
(
MHC
) in these striated muscle cells,
MHC
fractional degradative rates were measured in spontaneously beating cells and in arrested myocytes in which contractile activity was prevented by L-channel blockade (with verapamil, nifedipine, nisoldipine, and diltiazem) or K+ depolarization.
MHC
degradative rates were measured as the difference between rates of
MHC
synthesis and accumulation and in pulse-chase biosynthetic labeling experiments. Both methods indicated that contractile arrest markedly increased
MHC
degradation. Contractile arrest produced by L-channel blockade accelerated
MHC
degradation to a greater extent than K+ depolarization. The signal transduction pathway linking contractile activity to alterations in
MHC
degradation did not involve
protein kinase C
(
PKC
), because
MHC
degradation was unaffected by activating
PKC
in arrested cells or inhibiting
PKC
in spontaneously beating cells. Chloroquine and E-64 did not suppress the accelerated
MHC
degradation, suggesting that the rate-limiting step in
MHC
turnover occurred before degradative processing by cellular proteinases. Using a computer simulation, we hypothesize that the rate-limiting step in
MHC
turnover preceded (or was coincident with)
MHC
release from thick filaments. Thus mechanical forces may influence
MHC
half-life by regulating the rate of myosin disassembly.
...
PMID:Contractile arrest accelerates myosin heavy chain degradation in neonatal rat heart cells. 141 14
To determine whether spontaneous contractile activity affected the expression of
myosin heavy chain
isoenzymes in cultured neonatal rat heart cells, ventricular myocytes were isolated from 2-day-old rat pups by collagenase digestion and cultured for 24-96 h in the presence and absence of verapamil (10 microM), KCl (50 mM), or dihydropyridine receptor antagonists that produced contractile arrest. Inhibition of spontaneous contractile activity was associated with significant reductions in total
myosin heavy chain
(
MHC
) content and synthetic rates. Electrophoretic analysis of
MHC
isoenzymes indicated that
MHC
-beta protein rapidly disappeared from arrested cells, whereas
MHC
-alpha isoenzyme levels were less affected. In association with these protein changes, mRNA transcript levels for
MHC
-beta were markedly reduced in quiescent cells, whereas mRNA transcript levels for several other contractile protein genes were relatively less affected. Inhibition of contractile activity and
MHC
-beta expression were reversible upon removal of the arresting agents. Furthermore, the decrease in
MHC
-beta mRNA levels in arrested myocytes could be prevented by direct activation of
protein kinase C
with phorbol 12-myristate 13-acetate (without restoration of contractile activity). Conversely,
MHC
-beta mRNA levels in beating cells were reduced by treatment with staurosporine (a selective protein kinase C inhibitor). Thus contractile arrest (produced by either L-channel blockade or membrane depolarization) inhibited the accumulation of
MHC
-beta in cultured neonatal rat heart cells via a pretranslational mechanism. These effects may occur in response to the modulation of signaling system(s) involving mechanical "stretch" transduced via
protein kinase C
.
...
PMID:Contractile activity modulates myosin heavy chain-beta expression in neonatal rat heart cells. 171 69
The cardiac phenotype exhibits considerable plasticity, being under the regulation of numerous factors, such as developmental stage, functional load, as well as nutritional and hormonal states of the animal. Several lines of evidence indicate that the adrenergic nervous system plays an important role in the redistribution of myosin isoforms in the heart. For example, chemical sympathectomy favors the expression of V3 isomyosin at the expense of V1. In this study, we have examined the effect of adrenergic pathways on the expression of cardiac
myosin heavy chain
(
MHC
) genes. The level of cAMP was modulated by either adding forskolin or 8-bromo-cAMP to primary cultures of embryonic (18 d) cardiac myocytes. We have found that the level of mRNA coding for
MHC
-alpha was increased two- to three-fold. The effect was dose- and time-dependent and was potentiated further when the 8-Br-cAMP was given together with a phosphodiesterase inhibitor. The same changes were found in KCl arrested cells, indicating independence of contractile activity. Treatment of cells known to activate the
protein kinase C
(TPA) and inositol triphosphate pathways has increased the level of beta-
MHC
mRNA while that of alpha-MHC remained unchanged. These data lend strong support to direct effect of the adrenergic system on activity of cardiac genes.
...
PMID:The role of adrenergic system in regulation of cardiac myosin heavy chain gene expression. 183 53
In this article we summarize our recent experiments studying the phosphorylation of vertebrate myosin heavy chains by
protein kinase C
and casein kinase II. Protein kinase C phosphorylates vertebrate non-muscle myosin heavy chains both in vitro and in intact cells. A single serine residue near the end of the helical portion of the myosin rod is the only site phosphorylated in a variety of vertebrate nonmuscle myosin heavy chains. There does not appear to be a site for
protein kinase C
phosphorylation in vertebrate smooth muscle myosin heavy chains. Casein kinase II phosphorylates a single serine residue located near the carboxyl terminus of the 204 x 10(3) Mr smooth muscle myosin heavy chain in vitro as well as in cultured smooth muscle cells. It does not phosphorylate the 200 x 10(3) Mr smooth muscle myosin heavy chain. However, the site is present in vertebrate nonmuscle myosin heavy chains. The 204 x 10(3) Mr
myosin heavy chain
of embryonic chicken gizzard smooth muscle is exceptional in not containing a site for casein kinase II phosphorylation.
...
PMID:Phosphorylation of vertebrate smooth muscle and nonmuscle myosin heavy chains in vitro and in intact cells. 188 59
Two-dimensional mapping of the tryptic phosphopeptides generated following in vitro
protein kinase C
phosphorylation of the
myosin heavy chain
isolated from human platelets and chicken intestinal epithelial cells shows a single radioactive peptide. These peptides were found to comigrate, suggesting that they were identical, and amino acid sequence analysis of the human platelet tryptic peptide yielded the sequence -Glu-Val-Ser-Ser(PO4)-Leu-Lys-. Inspection of the amino acid sequence for the chicken intestinal epithelial cell
myosin heavy chain
(196 kDa) derived from cDNA cloning showed that this peptide was identical with a tryptic peptide present near the carboxyl terminal of the predicted alpha-helix of the myosin rod. Although other vertebrate nonmuscle myosin heavy chains retain neighboring amino acid sequences as well as the serine residue phosphorylated by
protein kinase C
, this residue is notably absent in all vertebrate smooth muscle myosin heavy chains (both 204 and 200 kDa) sequenced to date.
...
PMID:Identification of the serine residue phosphorylated by protein kinase C in vertebrate nonmuscle myosin heavy chains. 189
Cultured neonatal rat cardiac myocytes express at least three isozymes of
protein kinase C
(
PKC
), and two
PKC
isozymes are translocated to different intracellular sites on activation with alpha 1-adrenergic agonists or phorbol myristate acetate. Differential intracellular localization upon activation was compatible with differential function, and we therefore asked whether
PKC
isozymes had distinct roles in regulating transcription of the cardiac
myosin heavy chain
(
MHC
) genes. Cardiac myocytes were transfected with chloramphenicol acetyltransferase reporter plasmids containing the promoters of the beta-
MHC
or alpha-MHC isogenes. An alpha 1-adrenergic agonist stimulated the beta-
MHC
promoter by 3-fold but had no effect on the alpha-MHC promoter. This pattern of
MHC
promoter regulation by an alpha 1 agonist was the same as that found previously for the endogenous
MHC
mRNAs in this model system. Myocytes were then co-transfected with the beta- or alpha-MHC-chloramphenicol acetyltransferase plasmids and expression plasmids encoding wild-type or constitutively activated mutants of the alpha- and beta-isozymes of
PKC
. Co-transfection with wild-type alpha-
PKC
or wild-type beta-
PKC
did not stimulate the beta-
MHC
promoter, and none of the expressed PKCs affected the alpha-MHC promoter. However, the constitutively activated mutant of beta-
PKC
stimulated the beta-
MHC
promoter by 8-fold, whereas stimulation by the activated alpha-
PKC
mutant was only 40% as great (3-fold). In contrast, the constitutively activated alpha-
PKC
and beta-
PKC
mutants were equally potent in stimulating a reporter plasmid containing AP-1 recognition sequences. All transfected PKCs were expressed equally in the myocytes, as judged by immunofluorescence. These data indicate that transcription of the beta-
MHC
isogene is stimulated preferentially by beta-
PKC
in cardiac myocytes and provide direct evidence for differential functions of alpa-
PKC
and beta-
PKC
in transcriptional regulation.
...
PMID:Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene. 203 58
Changes in the phosphorylation of three high molecular weight cytoskeletal proteins in platelets (actin binding protein, platelet talin and
myosin heavy chain
) were investigated after treatment with a phorbol ester. All three showed rapid increases in phosphate incorporation, reaching near-maximal values within three minutes. Phosphopeptide maps of the proteins before and after phorbol treatment revealed a single new site in
myosin heavy chain
, two new peptides in actin binding protein, and multiple sites in talin. These results point to multiple cytoskeletal targets of
protein kinase C
and suggest complex mechanisms for reorganizing microfilaments.
...
PMID:Phosphorylation of high molecular weight proteins in platelets treated with 12-O-tetradecanoylphorbol-13-acetate. 234 2
We have examined the effect of
protein kinase C
phosphorylation on the actin-activated ATPase activity and filament stability of calf thymus myosin. Protein kinase C phosphorylated thymus myosin regulatory light chains, LC20, on two sites which are different from the site phosphorylated by myosin light chain kinase. The light meromyosin part of the thymus
myosin heavy chain
was also phosphorylated by
protein kinase C
, but at a rate about 10% that of LC20. Under conditions where both unphosphorylated thymus and myosin light chain kinase-phosphorylated thymus myosin were filamentous and under conditions where myosin light chain kinase phosphorylation induces myosin filament formation,
protein kinase C
phosphorylation had little effect on the actin-activated ATPase activity or filament stability of unphosphorylated or myosin light chain kinase-phosphorylated myosin. In contrast,
protein kinase C
phosphorylation has been reported to inhibit the actin-activated ATPase activity of gizzard myosin.
...
PMID:Protein kinase C phosphorylation of thymus myosin. 253 57
Treatment of human platelets with 162 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) resulted in phosphorylation of a number of peptides, including
myosin heavy chain
and the 20-kDa myosin light chain. The site phosphorylated on the
myosin heavy chain
was localized by two-dimensional peptide mapping to a serine residue(s) in a single major tryptic phosphopeptide. This phosphopeptide co-migrated with a tryptic peptide that was produced following in vitro phosphorylation of platelet
myosin heavy chain
using
protein kinase C
. The sites phosphorylated in the 20-kDa myosin light chain in intact cells were analyzed by two-dimensional mapping of tryptic peptides and found to correspond to Ser1 and Ser2 in the turkey gizzard myosin light chain. In vitro phosphorylation of purified human platelet myosin by
protein kinase C
showed that in addition to Ser1 and Ser2, a third site corresponding to Thr9 in turkey gizzard myosin light chain is also phosphorylated. The phosphorylatable myosin light chains from human platelets were found to consist of two major isoforms present in approximately equal amounts, but differing in their molecular weights and isoelectric points. A third, minor isoform was also visualized by two-dimensional gel electrophoresis. Following treatment with TPA, both the mono- and diphosphorylated forms of each isoform could be visualized, and the sites of phosphorylation were identified. The phosphate content rose from negligible amounts found prior to treatment with TPA to 1.2 mol of phosphate/mol of myosin light chain and 0.7 mol of phosphate/mol of
myosin heavy chain
following treatment. These results suggest that TPA mediates phosphorylation of both myosin light and heavy chains in intact platelets by activation of
protein kinase C
.
...
PMID:In situ phosphorylation of human platelet myosin heavy and light chains by protein kinase C. 291 6
alpha 1-Adrenergic agonists have negative inotropic effects on mammalian myocardium under some conditions, and biochemical experiments measuring the Ca(2+)-activated actomyosin ATPase activity of myofibrillar preparations suggest that this may result from a decrease in cross-bridge cycling rate caused by phosphorylation of myofilament proteins. Experiments with intact ventricular preparations, however, have failed to demonstrate a mechanical manifestation of a decrease in cycling rate. The present study examined the effect of alpha 1-adrenergic receptor stimulation on maximum shortening velocity in skinned single ventricular myocytes from rats. Enzymatically isolated myocytes were incubated with the beta-receptor antagonist propranolol in the presence or absence of the alpha 1-adrenergic receptor agonist phenylephrine and were then rapidly skinned to preserve the phosphorylation state of myofilament proteins. The velocity of unloaded shortening (Vo) was determined by use of the slack-test method and compared between skinned control and phenylephrine-treated cells. The relationship between isometric tension and [Ca2+] was also assessed for each myocyte. Vo was significantly lower in the alpha 1-adrenergic receptor agonist-treated cells than in the control cells, but there was no effect on Ca2+ sensitivity of isometric tension. In addition, the
myosin heavy chain
isoform composition accounted for a significant amount of the variation in Vo within the treatment groups. On the basis of these and previous results we propose that alpha 1-adrenergic receptor stimulation inhibits cross-bridge cycling rate at the level of myofilament proteins by a mechanism that may involve phosphorylation of troponin I by
protein kinase C
.
...
PMID:Alpha 1-adrenergic receptor stimulation decreases maximum shortening velocity of skinned single ventricular myocytes from rats. 778 69
1
2
3
4
5
6
7
Next >>